Anuh Pharma Limited (BOM:506260)

Anuh Pharma Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	-	80.6	195.57	72.02	19.27	37.96
Short-Term Investments	-	59.52	15.02	12.37	8.1	-
Trading Asset Securities	-	389.08	523.56	538.17	503.4	214.69
Cash & Short-Term Investments	529.19	529.19	734.15	622.56	530.77	252.65
Cash Growth	-27.92%	-27.92%	17.92%	17.29%	110.08%	91.21%
Accounts Receivable	-	2,386	2,159	1,899	1,712	1,357
Other Receivables	-	87.72	97.33	61.96	39.14	5.25
Receivables	-	2,482	2,261	1,968	1,756	1,370
Inventory	-	1,478	744.81	754	726.36	799.23
Prepaid Expenses	-	16.8	17.72	5.88	5.72	4.79
Restricted Cash	-	-	-	-	30.5	-
Other Current Assets	-	7.3	3.54	35.29	26.61	159.98
Total Current Assets	-	4,513	3,762	3,385	3,076	2,587
Property, Plant & Equipment	-	560.92	583.66	492.42	526.76	613.41
Long-Term Investments	-	395.83	619.55	517.14	396.84	212.13
Other Intangible Assets	-	5.29	1.21	1.58	1.31	1.83
Long-Term Deferred Tax Assets	-	38.62	20.8	4.22	7.68	-
Other Long-Term Assets	-	58.97	77.76	53.99	41.09	57.51
Total Assets	-	5,574	5,066	4,457	4,050	3,472

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	-	1,877	1,568	1,405	1,528	1,216
Accrued Expenses	-	6.96	7.08	6.16	4.74	3.34
Short-Term Debt	-	-	104.98	20.13	-	31.11
Current Portion of Leases	-	0.58	3.3	2.91	0.67	2.06
Current Income Taxes Payable	-	23.16	5.48	-	-	-
Other Current Liabilities	-	122.75	95.85	92.72	80.29	56.81
Total Current Liabilities	-	2,030	1,785	1,527	1,613	1,309
Long-Term Leases	-	-	0.58	3.88	8.39	9.07
Pension & Post-Retirement Benefits	-	12.21	12.92	11.05	9.91	9.72
Long-Term Deferred Tax Liabilities	-	-	-	-	-	0.48
Other Long-Term Liabilities	-	9.21	7.39	2.75	5.93	5.69
Total Liabilities	-	2,051	1,806	1,545	1,638	1,334

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	-	501.12	250.56	250.56	250.56	250.56
Retained Earnings	-	3,018	3,009	2,660	2,160	1,886
Comprehensive Income & Other	-	2.99	1.14	1.31	1.69	1.3
Shareholders' Equity	3,522	3,522	3,260	2,912	2,412	2,138
Total Liabilities & Equity	-	5,574	5,066	4,457	4,050	3,472

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	0.58	0.58	108.86	26.93	9.07	42.24
Net Cash (Debt)	528.61	528.61	625.28	595.63	521.7	210.41
Net Cash Growth	-15.46%	-15.46%	4.98%	14.17%	147.94%	-
Net Cash Per Share	5.27	5.27	12.48	5.94	5.21	2.10
Filing Date Shares Outstanding	100.22	100.22	100.22	100.22	100.22	100.22
Total Common Shares Outstanding	100.22	100.22	100.22	100.22	100.22	100.22
Working Capital	-	2,483	1,977	1,858	1,463	1,278
Book Value Per Share	35.14	35.14	32.53	29.06	24.07	21.33
Tangible Book Value	3,517	3,517	3,259	2,911	2,411	2,136
Tangible Book Value Per Share	35.09	35.09	32.52	29.04	24.06	21.31
Land	-	15.59	15.59	15.59	113.07	113.07
Buildings	-	148.57	146.73	146.73	146.73	146.73
Machinery	-	1,032	941.3	767.32	723.6	713.5
Construction In Progress	-	-	2.72	4.54	-	1

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 13, 2026

Data Sources Report a data error